Azenta, Inc. (0HQ1.L)

52.56 +1.61 (+3.16%) At close: 02:35PM BST

Azenta, Inc.

200 Summit Drive
Burlington, MA 01803
United States
978 262 2626
https://www.azenta.com

Sector(s): 
Industry: 
Full-time employees: 3,500

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Stephen S. Schwartz	CEO, President & Director	1.05M	N/A	1959
Mr. Robin Vacha	Senior Vice President of Global Operations	533.35k	N/A	1976
Mr. Jason W. Joseph	Senior VP, General Counsel & Corporate Secretary	544.13k	N/A	1971
Mr. Herman Cueto	Executive VP & CFO	N/A	N/A	1974
Ms. Violetta Hughes	VP & Chief Accounting Officer	N/A	N/A	1972
Mr. Michael Paulo	VP and Chief Information & Digital Officer	N/A	N/A	N/A
Mr. John E. O'Brien	Senior Vice President of Corporate Development	N/A	N/A	1970
Ms. Olga Pirogova	Senior VP & Chief HR Officer	N/A	N/A	1974
Mr. J. Robert Woodward	Senior Vice President of Global Quality & Regulatory	N/A	N/A	N/A
Dr. Ginger Zhou Ph.D.	Senior VP & GM of Multiomics and Synthesis Solutions	N/A	N/A	1977

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Corporate governance

Azenta, Inc.’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 8; Board: 2; Shareholder rights: 6; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.